ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 624512 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 624512; 2) Community: the network communities that were significantly associated with the response to NSC 624512; 3) Molecule: the relationships between components within communities and NSC 624512; 4) MDR: the compounds that were significantly associated with the NSC 624512.

NSC Compound Enrichment Correlation
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0164116791870036 0.50386275
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0164116791870036 0.38008718
NSC 694075 Null 0.0164116791870036 0.36318535
NSC 697504 Null 0.0164116791870036 0.45997684
NSC 700363 Liposomal Annamycin 0.0164116791870036 0.085541914
NSC 715974 Null 0.0164116791870036 0.38496424
NSC 721154 11-Cyanomethylen-2-methoxy-6-methyl-11H-indolo[1,2-b]indazol ium trifluoromethanesulfonate 0.0164116791870036 0.0066160229
NSC 726365 Null 0.0164116791870036 0.36252991
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0164116791870036 0.15082674
NSC 732737 Null 0.0164116791870036 0.2912647
Total:58  Current:16    [First] [Prev] [Next] [Last]